miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
BACKGROUND: Clear cell renal cancer frequently harbours von Hippel-Lindau (VHL) gene mutations, leading to stabilisation of the hypoxia-inducible factors (HIFs) and expression of their target genes. We investigated HIF-1 and HIF-2 in the regulation of microRNA-210 (miR-210), and its clinical relevan...
Asıl Yazarlar: | McCormick, R, Blick, C, Ragoussis, J, Schoedel, J, Mole, D, Young, A, Selby, P, Banks, R, Harris, A |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2013
|
Benzer Materyaller
-
MiR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis
Yazar:: McCormick, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
The role of hypoxia-inducible MIR-210 in the biology and prognosis of clear cell kidney cancer
Yazar:: McCormick, I, ve diğerleri
Baskı/Yayın Bilgisi: (2011) -
MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU
Yazar:: Favaro, E, ve diğerleri
Baskı/Yayın Bilgisi: (2010) -
MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU.
Yazar:: Elena Favaro, ve diğerleri
Baskı/Yayın Bilgisi: (2010-04-01) -
New insights into the pathology of pulmonary hypertension: implication of the miR‐210/ISCU1/2/Fe‐S axis
Yazar:: Haiyang Tang, ve diğerleri
Baskı/Yayın Bilgisi: (2015-04-01)